Global Bio-chem Technology Group Company Limited (GBCMY) Stock Price & Analysis
Global Bio-chem Technology Group Company Limited (GBCMY) — price $4.14 (0.00%), as of the Nov 19, 2026 trading session; market cap $139M.
Educational signal · not a buy or sell recommendation · How to read this
Global Bio-chem Technology Group Company Limited · GBCMY
Global Bio-chem Technology Group Company Limited (GBCMY) specializes in the production and sale of corn-derived biochemical products, operating primarily in the packaged foods sector.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $4.14 | |
| Change on the day | 0.00% | |
| 52-week range | $0.4137 – $4.87 | |
| Market capitalisation | $139M | — |
| Price / earnings (trailing) | 1.60 | |
| Shares traded on the day | 150 |
Price & events
Other perspectives
Council score for Global Bio-chem Technology Group Company (GBCMY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Global Bio-chem Technology Group Company (GBCMY), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Global Bio-chem Technology Group Company Limited (GBCMY) is the company analyzed here. It employs 1,890 people and is led by Yu Feng Sha. In Q2 FY2026 it reported revenue of HK$1.01B and net income of -HK$207M. The market values it at $139M.
What do the latest results show for Global Bio-chem Technology Group Company (GBCMY)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of HK$1.01B.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | HK$1.01B | -HK$207M | -HK$6.00 (diluted) |
| Q4 FY2025 | HK$1.09B | HK$310M | HK$115.00 (diluted) |
| Q2 FY2025 | HK$1.19B | -HK$155M | -HK$87.00 (diluted) |
| Q4 FY2024 | HK$1.10B | HK$927M | HK$500.00 (diluted) |
What are the financial strengths and risks for Global Bio-chem Technology Group Company (GBCMY)?
Short answer · as of
The distress and quality screens read Altman Z -0.38 · Piotroski F 3. Trailing ratios: ROE -15.6% · ROA 2.1% · current ratio 0.48 · earnings yield 18.8% · free-cash-flow yield -10.4%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -0.38 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-15.6%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held GBCMY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported GBCMY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: GBCMY Stock
These answers are editorial: 1 of these 8 answers is drawn from the GBCMY research dossier (written Jun 15, 2026 by gpt-4o-mini); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is GBCMY a good stock to buy?
Stock Expert AI does not rate GBCMY buy, sell or hold. Global Bio-chem Technology Group Company Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the GBCMY stock price today?
The last price recorded for Global Bio-chem Technology Group Company Limited (GBCMY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for GBCMY?
Global Bio-chem Technology Group Company Limited faces several risks, including intense competition from established biochemical producers that could impact market share. Economic fluctuations can affect consumer demand for its products, while currency risk poses a threat to the value of investments for U.S. holders, given the company's foreign operations.
What are the key factors to evaluate for GBCMY?
Evaluate GBCMY on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Sustainability Initiatives: As industries increasingly prioritize sustainability, Global Bio-chem's focus on corn-derived products aligns with global trends. Not financial advice.
How frequently does GBCMY data refresh on this page?
GBCMY's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven GBCMY's recent stock price performance?
Global Bio-chem Technology Group Company Limited (GBCMY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio catering to multiple industries. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GBCMY overvalued or undervalued right now?
The trailing P/E of Global Bio-chem Technology Group Company Limited (GBCMY) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research GBCMY before investing?
Before investing in Global Bio-chem Technology Group Company Limited (GBCMY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 14 figures on this page — 8 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com